ArticleBMC cancer2025

Characterization of clinical risk factors for enhanced molecular residual disease monitoring in resected early-stage non-small cell lung cancer.

Yunfei Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.